Evidence map›Paper›PMID 41071789›Full record

ArticlePloS one2025

Fecal carriage and associated factors of extended-spectrum beta-lactamase-producing Enterobacteriaceae in children under five years old with diarrhea at a tertiary hospital in Tanzania.

Emily M Jackson, Doreen Kamori, Ambele M Mwandigha, Vulstan J Shedura, Upendo Kibwana, Mariam Mirambo, Agricola Joachim, Joel Manyahi, Mtebe V Majigo

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emily M JacksonDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Doreen KamoriDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID https://orcid.org/0000-0001-5162-6554
Ambele M MwandighaDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Vulstan J SheduraDepartment of Clinical Research, Training and Consultancy, Southern Zone Referral Hospital, Mtwara, Tanzania.ORCID https://orcid.org/0000-0002-1939-2492
Upendo KibwanaDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Mariam MiramboDepartment of Microbiology and Immunology, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Agricola JoachimDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Joel ManyahiDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID https://orcid.org/0000-0002-1388-3901
Mtebe V MajigoDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.ORCID https://orcid.org/0000-0003-3726-2816

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of extended-spectrum beta-lactamase-producing Enterobacteriales (ESBL-PE) is high in resource-limited settings. Carriage in young children has been linked to increased morbidity and mortality. However, there is limited information on the prevalence of ESBL-PE among children under five in our settings. This study aimed to determine the fecal carriage of ESBL-PE in children under five years old suffering from diarrhea at a tertiary hospital in Tanzania. METHODOLOGY: This cross-sectional study was conducted over a three-month period at Muhimbili National Hospital in Dar es Salaam, Tanzania. Participants' socio-demographic and clinical information were collected using a structured questionnaire and the child's clinic card. Stool samples were collected and screened for the presence of ESBL-PE using MacConkey agar supplemented with ceftazidime. Confirmation of ESBL-PE was achieved through a double disk synergy test. Logistic regression analysis was employed to identify factors independently associated with ESBL-PE carriage. A p-value of less than 0.05 was considered statistically significant.

resultsWe enrolled 181 children with a median age of 29 months (interquartile range: 20-37). The female-to-male ratio was 1:1. Among all participants, 54.1% (98/181) were malnourished, and the parents of 54.1% (98/181) had low levels of education. The overall fecal carriage rate of ESBL-PE was 65.7% (119/181). A total of 120 ESBL-PE isolates were confirmed. E. coli was the predominant ESBL-PE, contributing to (74.2%, 89/120), followed by K. pneumoniae (21/120, 17.5%), K. oxytoca (8/120, 6.7%), and Citrobacter spp. (2/120, 1.7%). Malnourished children had a higher carriage rate of ESBL-PE (77.6%) compared to non-malnourished children (51.8%) (p = 0.0003). Prolonged hospital stay (aOR=1.12, 95% CI = 1.05-1.19, p = 0.001), malnourishment (aOR=3.15, 95% CI = 1.61-6.19, p = 0.001), and a history of antibiotic use (aOR=2.28, 95% CI = 1.15-4.54, p = 0.018) were independently associated with the carriage of ESBL-PE. Furthermore, we observed that ESBL-producing E. coli isolated from malnourished children had high resistance rates of 75% and 65% against aztreonam and sulfamethoxazole/trimethoprim, respectively, while ESBL-producing K. pneumoniae isolated from the same group exhibited high resistance rates of 84.6% and 69.2%.

conclusionThe present study revealed that children under five years old with diarrhea have a higher rate of ESBL-PE fecal carriage. Furthermore, prolonged hospital stays, malnutrition, and a history of antibiotic use are independently associated with ESBL-PE carriage. We also report high resistance rates of ESBL-PE isolated from malnourished children. These findings emphasize the importance of enhancing infection prevention and control measures to mitigate the spread of multidrug-resistant pathogens in both hospital and community settings.

Indexed as

beta-LactamasesDiarrheaEnterobacteriaceaeEnterobacteriaceae InfectionsFecesChild, PreschoolCross-Sectional StudiesFemaleHumansInfantMalePrevalenceTanzaniaTertiary Care Centersbeta-Lactamases

Identifiers

PMID41071789
PMCPMC12513625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.